The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Bacterial Reverse Mutation Test of CP pharmacopunture

세균을 이용한 CP 약침의 복귀돌연변이 시험

  • Hwang, Ji Hye (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University) ;
  • Ku, Jaseung (Bogwang korean medical clinic) ;
  • Jung, Chul (Namsangcheon Korean Medicine Clinic)
  • Received : 2020.06.11
  • Accepted : 2020.08.10
  • Published : 2020.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to evaluate the toxicity of CP pharmacopunture using bacterial reverse mutation test. Methods: To determine the mutagenic potential of CP pharmacopunture, histidine requiring Salmonella typhimurium (TA98, TA100, TA1535, and TA1537) and tryptophan requiring Escherichia coli (WP2uvrA, pKM101) strains were used. The negative (normal saline solution) and positive (Sodium azide, 2-Nitrofluorene, 2-Aminoanthracene, 9-Aminoacridine, and 4-Nitroquinoline N-oxide) control groups were used. To determine the dose levels of the main study, a dose range-finding study was conducted. Results: As a results of the dose range-finding study, the growth inhibition by CP pharmacopunture was not evident at any dose levels in the absence and presence of metabolic activation. As a results of the main study, the mean number of revertant colonies was less than twice when compared to the negative control values at all dose levels of the CP pharmacopuncture in the presence and absence of metabolic activation, showing no dose-related increase. In the positive control group, the number of revertant colonies was markedly increased by more than twice when compared to the negative control group. Conclusion: According to the results of this study, CP pharmacopunture did not show any signs of mutagenic potential.

Keywords

References

  1. Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Kyungrak medical publishing co. Chungnam 2011 : 127-33.
  2. Nam SC. Immune Pharmacopuncturology. Kyungrak medical publishing co. Chungnam, 2009.
  3. Korean Acupuncture & Moxibustion Society. Hanmi Medical Publishing Co., Seoul, 2020.
  4. Ramirez-Barrantes R, Cordova C, Gatica S, Rodriguez B, Lozano C, Marchant I, et al. Transient receptor potential vanilloid 1 expression mediates capsaicin-induced cell death. Frontiers in physiology. 2018;9:682. https://doi.org/10.3389/fphys.2018.00682
  5. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy: controlled study with long-term follow-up. Diabetes care. 1992;15(1):8-14. https://doi.org/10.2337/diacare.15.1.8
  6. Drake HF. Justins, Randomised double-blind study of topical capsaicin for treatment of post-herpetic neuralgia. Pain 1990;5:S58. https://doi.org/10.1016/0304-3959(90)92254-N
  7. Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk Jr HH. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. Journal of the American Academy of Dermatology. 1986;15(3):504-507. https://doi.org/10.1016/S0190-9622(86)70201-6
  8. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, Turini D. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. The Journal of urology. 1989;142(1):150-154. https://doi.org/10.1016/S0022-5347(17)38701-3
  9. Silva C, Rio ME, Cruz F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. European urology. 2000;38(4):444-452. https://doi.org/10.1159/000020322
  10. McCarty MF, DiNicolantonio JJ, O'keefe JH. Capsaicin may have important potential for promoting vascular and metabolic health. Open Heart. 2015;2(1):e000262. https://doi.org/10.1136/openhrt-2015-000262
  11. Westerterp-Plantenga MS, Smeets A, Lejeune MPG. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int. J. Obes. 2005;29(6):682-688. https://doi.org/10.1038/sj.ijo.0802862
  12. Steinberg AC, Oyama IA, Rejba AE, Kellogg-Spadt S, Whitmore KE. Capsaicin for the treatment of vulvar vestibulitis. American journal of obstetrics and gynecology. 2005;192(5):1549-1553. https://doi.org/10.1016/j.ajog.2004.10.626
  13. Zhang J, Nagasaki M, Tanaka Y, Morikawa S. Capsaicin inhibits growth of adult T-cell leukemia cells. Leukemia research. 2003;27(3):275-283. https://doi.org/10.1016/S0145-2126(02)00164-9
  14. Ito K, Nakazato T, Yamato K, Miyakawa Y Yamada T, Hozumi N, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer research. 2004;64(3):1071-1078. https://doi.org/10.1158/0008-5472.CAN-03-1670
  15. Hail Jr N, Lotan R. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. Journal of the National Cancer Institute. 2001;94(17):1281-1292. https://doi.org/10.1093/jnci/94.17.1281
  16. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81(1-2):135-145. https://doi.org/10.1016/S0304-3959(99)00007-X
  17. Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. Journal of the American Academy of Dermatology. 2001;44(3):471-478. https://doi.org/10.1067/mjd.2001.110059
  18. Ehsani AH, Toosi S, Seirafi H, Akhyani M, Hosseini M, Azadi R, et al. Capsaicin vs. clobetasol for the treatment of localized alopecia areata. Journal of the European Academy of Dermatology and Venereology. 2009;23(12):1451-1453.
  19. Kim HJ, Gwan R, Han JW, Jung C. Anti-oxidant and anti-inflammatory effects of V Yakchim. J Korea Immuno-Yakchim Soc 2013:2(1):1-8.
  20. Kim HJ. In Vitro Chromosome Aberration Test of V-YAKCHIM in Chinese Hamster Lung Cell. J Korea Immuno-Yakchim Soc 2013:2(2):19-27.
  21. Jung C. In vivo Micronucleus test of V-YAKCHIM in ICR Mice. J Korea Immuno-Yakchim Soc 2013:2(2):5-10.
  22. Lee MS, Jung C. Comparative Sutdies on the Biological Activity of V and A Yakchim. J Korea Immuno-Yakchim Soc 2015:4(2):37-45.
  23. Cho S, Jung C, Kim K, Ko S, Jung H, Park J. A Case Study of Acute Appendicitis Improved by Pharmacopuncture Treatment. The Journal of Internal Korean Medicine. 2019;40(2):208-219. https://doi.org/10.22246/jikm.2019.40.2.208
  24. Chung YJ, Lee HJ, Lee YK, Lee JH, Gong HM, Jun SA, et al. Case Report of Hypoesthesia of Lower Limb with Additional CP Pharmacopuncture. Journal of Physiology & Pathology in Korean Medicine. 2019;33(2):158-162. https://doi.org/10.15188/kjopp.2019.04.33.2.158
  25. Hwang JH, Ku J, Jung C. Evaluation of the Single-Dose Toxicity of Capsaicin Containing Pharmacopuncture in Rats. Journal of Acupuncture Research. 2020;37(3):167-172. https://doi.org/10.13045/jar.2020.00185
  26. Teschke R, Wolff A, Frenzel C, Schulze J. Review article: Herbal hepatotoxicity-an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40(1):32-50. https://doi.org/10.1111/apt.12798
  27. Kim EJ, Chen Y, Huang JQ, Li KM, Razmovski -Naumovski V, Poon J, Chan K, Roufogalis BD, McLachlan AJ, Mo SL, Yang D, Yao M, Liu Z, Liu J, Li GQ. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J Ethnopharmacol. 2013;146(1):40-61. https://doi.org/10.1016/j.jep.2012.12.027
  28. Korea Food and Drug Administration (KFDA). Good Laboratory Practice (GLP), 2017. http://www.law.go.kr/admRulInfoP.do?admRulSeq=2100000086689.
  29. China Food and Drug Administration (CFDA). Good Laboratory Practice for Non-Clinical Laboratory Studies of Drug: Notification No. 34. 2017.
  30. Organisation for Economic Co-operation and Development.OECD Principles of Good Laboratory Practice. OECD ENV/MC/CHEM(98)17. 1997.
  31. Korea Food and Drug Administration (KFDA). Toxicity test standard of drugs. 2017.
  32. National Instutute of food and drug safety evaluation. Explanation of toxicity test standard of drugs. 2012.

Cited by

  1. 급성기 허리 및 고관절 통증에 대한 CP 약침을 포함한 한의 치료 3례 증례보고 vol.37, pp.3, 2020, https://doi.org/10.14406/acu.2020.020